Get startedLog in
    Picture of Lasa Supergenerics logo

    LASA — Lasa Supergenerics Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Lasa Supergenerics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    C2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,6732,0241,3711,2961,043
    Cost of Revenue
    Gross Profit726900400164291
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,5451,7101,4271,6761,216
    Operating Profit128314-55.6-380-173
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes47.4295-61.4-423-191
    Provision for Income Taxes
    Net Income After Taxes36.3228-53.3-386-217
    Net Income Before Extraordinary Items
    Net Income36.3228-53.3-386-217
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income36.3228-53.3-386-217
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.45.6-0.056-5.22-3.2
    Dividends per Share